| Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand N Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College London 10, 77482, 2020 | 5003 | 2020 |
| Estimates of the severity of coronavirus disease 2019: a model-based analysis R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... The Lancet infectious diseases 20 (6), 669-677, 2020 | 4445 | 2020 |
| Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, W C, ... Nature 584, 257-261, 2020 | 3925 | 2020 |
| Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ... Nature 584 (7821), 425-429, 2020 | 1025 | 2020 |
| The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ... Science, 2020 | 935 | 2020 |
| Report 12: The global impact of COVID-19 and strategies for mitigation and suppression P Walker, C Whittaker, O Watson, M Baguelin, K Ainslie, S Bhatia, S Bhatt, ... | 694* | 2020 |
| Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 564 | 2021 |
| Suppression of COVID-19 outbreak in the municipality of Vo, Italy E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ... medRxiv, 2020 | 381 | 2020 |
| Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College COVID-19 Response Team, 20, 2020 | 377 | 2020 |
| Report 3: transmissibility of 2019-nCoV N Imai, A Cori, I Dorigatti, M Baguelin, CA Donnelly, S Riley, ... Imperial College London, 2020 | 364 | 2020 |
| Countering the Zika epidemic in Latin America NM Ferguson, ZM Cucunubá, I Dorigatti, GL Nedjati-Gilani, CA Donnelly, ... Science 353 (6297), 353-354, 2016 | 311 | 2016 |
| Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China N Imai, I Dorigatti, A Cori, C Donnelly, S Riley, N Ferguson | 278* | 2020 |
| Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment NM Ferguson, I Rodríguez-Barraquer, I Dorigatti, L Mier-y-Teran-Romero, ... Science 353 (6303), 1033-1036, 2016 | 271 | 2016 |
| Estimates of the severity of COVID-19 disease R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... MedRxiv, 2020 | 256 | 2020 |
| Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks M Lipsitch, CA Donnelly, C Fraser, IM Blake, A Cori, I Dorigatti, ... PLOS Negl Trop Dis 9 (7), e0003846, 2015 | 238 | 2015 |
| West African Ebola epidemic after one year—slowing but not yet under control WHOER Team N Engl J Med 2015 (372), 584-587, 2015 | 218 | 2015 |
| The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ... PLoS medicine 13 (11), e1002181, 2016 | 205 | 2016 |
| Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18 (1), 1-12, 2020 | 198 | 2020 |
| State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 1-9, 2020 | 172 | 2020 |
| Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ... Wellcome Open Research 5, 2020 | 148 | 2020 |
